Human MDR1 encodes an ATP-binding cassette transporter, P-glycoprotein, that mediates multiple drug resistance (MDR) to antitumor agents. It has been previously shown that photoaffinity drug-labeling sites reside within, or near, the last transmembrane loop of each cassette within P-glycoprotein (transmembrane domains (TM) 5-6 and 11-12). A genetic approach was used to determine if the drug-labeling site in the second cassette contains functionally important amino acids. Since human MDR3 is 77% identical to MDR1 but does not mediate MDR, the region from TM10 to the C terminus of MDR1 was replaced with the corresponding sequences from MDR3. The resultant chimeric protein was expressed but not functional. By using progressively smaller replacements, we show that replacements limited to TM12 markedly impaired resistance to actinomycin D, vincristine, and doxorubicin, but not to colchicine. The phenotype was associated with an impaired ability to photoaffinity label the chimeric P-glycoprotein with [I]iodoaryl azidoprazosin. In contrast, replacement of the loop between TM11 and 12 appears to create a more efficient drug pump for actinomycin D, colchicine, and doxorubicin, but not vincristine. These results suggest that, similar to voltage-gated ion channels, amino acids within and immediately N-terminal to the last transmembrane domain of P-glycoprotein compose part of the drug-binding pocket and are in close proximity to photoaffinity drug-labeling domains.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				Y. Yang, Q. Chen, and J.-T. Zhang Structural and Functional Consequences of Mutating Cysteine Residues in the Amino Terminus of Human Multidrug Resistance-associated Protein 1 J. Biol. Chem., November 8, 2002; 277(46): 44268 - 44277. [Abstract] [Full Text] [PDF]

				D. J. Gruol, M. N. King, and M. E. Kuehne Evidence for the Locations of Distinct Steroid and Vinca Alkaloid Interaction Domains within the Murine mdr1b P-Glycoprotein Mol. Pharmacol., November 1, 2002; 62(5): 1238 - 1248. [Abstract] [Full Text] [PDF]

				D. J. Gruol, J. Bernd, A. E. Phippard, I. Ojima, and R. J. Bernacki The Use of a Novel Taxane-Based P-Glycoprotein Inhibitor to Identify Mutations That Alter the Interaction of the Protein with Paclitaxel Mol. Pharmacol., July 1, 2001; 60(1): 104 - 113. [Abstract] [Full Text]

				M. Putman, H. W. van Veen, and W. N. Konings Molecular Properties of Bacterial Multidrug Transporters Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 672 - 693. [Abstract] [Full Text] [PDF]

				Y. Zhou, M. M. Gottesman, and I. Pastan Domain Exchangeability between the Multidrug Transporter (MDR1) and Phosphatidylcholine Flippase (MDR2) Mol. Pharmacol., November 1, 1999; 56(5): 997 - 1004. [Abstract] [Full Text]

				T. W. Loo and D. M. Clarke The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface J. Biol. Chem., August 27, 1999; 274(35): 24759 - 24765. [Abstract] [Full Text] [PDF]

				Q. D. Vo and D. J. Gruol Identification of P-glycoprotein Mutations Causing a Loss of Steroid Recognition and Transport J. Biol. Chem., July 16, 1999; 274(29): 20318 - 20327. [Abstract] [Full Text] [PDF]

				Y. Zhou, M. M. Gottesman, and I. Pastan Studies of Human MDR1-MDR2 Chimeras Demonstrate the Functional Exchangeability of a Major Transmembrane Segment of the Multidrug Transporter and Phosphatidylcholine Flippase Mol. Cell. Biol., February 1, 1999; 19(2): 1450 - 1459. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Superfolding of the Partially Unfolded Core-glycosylated Intermediate of Human P-glycoprotein into the Mature Enzyme Is Promoted by Substrate-induced Transmembrane Domain Interactions J. Biol. Chem., June 12, 1998; 273(24): 14671 - 14674. [Abstract] [Full Text] [PDF]

				R. Egner, F. E. Rosenthal, A. Kralli, D. Sanglard, and K. Kuchler Genetic Separation of FK506 Susceptibility and Drug Transport in the Yeast Pdr5 ATP-binding Cassette Multidrug Resistance Transporter Mol. Biol. Cell, February 1, 1998; 9(2): 523 - 543. [Abstract] [Full Text]

				G. Merino and H. A. Shuman Truncation of MalF Results in Lactose Transport via the Maltose Transport System of Escherichia coli J. Biol. Chem., January 23, 1998; 273(4): 2435 - 2444. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate J. Biol. Chem., December 19, 1997; 272(51): 31945 - 31948. [Abstract] [Full Text] [PDF]

				J. Wang and K. M. Giacomini Molecular Determinants of Substrate Selectivity in Na+-dependent Nucleoside Transporters J. Biol. Chem., November 14, 1997; 272(46): 28845 - 28848. [Abstract] [Full Text] [PDF]

				S. Dey, M. Ramachandra, I. Pastan, M. M. Gottesman, and S. V. Ambudkar Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein PNAS, September 30, 1997; 94(20): 10594 - 10599. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12 J. Biol. Chem., August 22, 1997; 272(34): 20986 - 20989. [Abstract] [Full Text] [PDF]

				A. Demmer, H. Thole, P. Kubesch, T. Brandt, M. Raida, R. Fislage, and B. Tummler Localization of the Iodomycin Binding Site in Hamster P-glycoprotein J. Biol. Chem., August 15, 1997; 272(33): 20913 - 20919. [Abstract] [Full Text] [PDF]

				S. Scala, N. Akhmed, U. S. Rao, K. Paull, L.-B. Lan, B. Dickstein, J.-S. Lee, G. H. Elgemeie, W. D. Stein, and S. E. Bates P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups Mol. Pharmacol., June 1, 1997; 51(6): 1024 - 1033. [Abstract] [Full Text]

				T. W. Loo and D. M. Clarke Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332in Predicted Transmembrane Segments (TM) 6and 975in Predicted TM12 of Human P-glycoprotein by Drug Substrates J. Biol. Chem., November 1, 1996; 271(44): 27482 - 27487. [Abstract] [Full Text] [PDF]

				R. A. Vaughan and M. J. Kuhar Dopamine Transporter Ligand Binding Domains. STRUCTURAL AND FUNCTIONAL PROPERTIES REVEALED BY LIMITED PROTEOLYSIS J. Biol. Chem., August 30, 1996; 271(35): 21672 - 21680. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Mutational Analysis of the Predicted First Transmembrane Segment of Each Homologous Half of Human P-glycoprotein Suggests That They Are Symmetrically Arranged in the Membrane J. Biol. Chem., June 28, 1996; 271(26): 15414 - 15419. [Abstract] [Full Text] [PDF]

				C. Kast, V. Canfield, R. Levenson, and P. Gros Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence J. Biol. Chem., April 19, 1996; 271(16): 9240 - 9248. [Abstract] [Full Text] [PDF]

				N. Shani, A. Sapag, and D. Valle Characterization and Analysis of Conserved Motifs in a Peroxisomal ATP-binding Cassette Transporter J. Biol. Chem., April 12, 1996; 271(15): 8725 - 8730. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Covalent Modification of Human P-glycoprotein Mutants Containing a Single Cysteine in Either Nucleotide-binding Fold Abolishes Drug-stimulated ATPase Activity J. Biol. Chem., September 29, 1995; 270(39): 22957 - 22961. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke P-glycoprotein J. Biol. Chem., September 15, 1995; 270(37): 21839 - 21844. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular Rulers J. Biol. Chem., September 28, 2001; 276(40): 36877 - 36880. [Abstract] [Full Text] [PDF]

				I. L. Urbatsch, K. Gimi, S. Wilke-Mounts, and A. E. Senior Conserved Walker A Ser Residues in the Catalytic Sites of P-glycoprotein Are Critical for Catalysis and Involved Primarily at the Transition State Step J. Biol. Chem., August 4, 2000; 275(32): 25031 - 25038. [Abstract] [Full Text] [PDF]

				S. Ryu, T. Kawabe, S. Nada, and A. Yamaguchi Identification of Basic Residues Involved in Drug Export Function of Human Multidrug Resistance-associated Protein 2 J. Biol. Chem., December 8, 2000; 275(50): 39617 - 39624. [Abstract] [Full Text] [PDF]

				I. L. Urbatsch, K. Gimi, S. Wilke-Mounts, N. Lerner-Marmarosh, M.-E. Rousseau, P. Gros, and A. E. Senior Cysteines 431 and 1074 Are Responsible for Inhibitory Disulfide Cross-linking between the Two Nucleotide-binding Sites in Human P-glycoprotein J. Biol. Chem., July 13, 2001; 276(29): 26980 - 26987. [Abstract] [Full Text] [PDF]

				K.-i. Ito, S. L. Olsen, W. Qiu, R. G. Deeley, and S. P. C. Cole Mutation of a Single Conserved Tryptophan in Multidrug Resistance Protein 1 (MRP1/ABCC1) Results in Loss of Drug Resistance and Selective Loss of Organic Anion Transport J. Biol. Chem., May 4, 2001; 276(19): 15616 - 15624. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil J. Biol. Chem., April 27, 2001; 276(18): 14972 - 14979. [Abstract] [Full Text] [PDF]

				T. W. Loo and D. M. Clarke Cross-linking of Human Multidrug Resistance P-glycoprotein by the Substrate, Tris-(2-maleimidoethyl)amine, Is Altered by ATP Hydrolysis. EVIDENCE FOR ROTATION OF A TRANSMEMBRANE HELIX J. Biol. Chem., August 17, 2001; 276(34): 31800 - 31805. [Abstract] [Full Text] [PDF]